16 In our study, despite the low prevalence rates of GLP-1 receptor agonists and SGLT2 inhibitors, there was an increasing trend over the study period.
← all excerpts
Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands.
1
—
—